Weiss Multi-Strategy Advisers LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 81 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$76,000
-54.2%
30,000
-50.0%
0.00%
-57.1%
Q2 2017$166,000
+24.8%
60,000
-11.8%
0.01%
+40.0%
Q1 2017$133,000
+87.3%
68,0000.0%0.01%
+66.7%
Q4 2016$71,000
-4.1%
68,0000.0%0.00%
-40.0%
Q3 2016$74,000
+51.0%
68,000
-1.8%
0.01%
+25.0%
Q2 2016$49,000
-65.7%
69,255
-43.2%
0.00%
-33.3%
Q1 2016$143,000
-52.2%
122,0000.0%0.01%
-71.4%
Q4 2015$299,000
-18.3%
122,0000.0%0.02%
+31.2%
Q3 2015$366,000
-31.8%
122,000
-6.2%
0.02%
-23.8%
Q2 2015$537,000
-16.2%
130,000
-12.2%
0.02%
-25.0%
Q1 2015$641,000
+34.9%
148,000
-7.5%
0.03%
+75.0%
Q4 2014$475,000
-4.6%
160,000
+6.7%
0.02%
+33.3%
Q3 2014$498,000
-6.2%
150,000
-28.6%
0.01%0.0%
Q2 2014$531,000
+135.0%
210,000
+110.0%
0.01%
+140.0%
Q1 2014$226,000100,0000.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders